JP2016520636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520636A5 JP2016520636A5 JP2016517274A JP2016517274A JP2016520636A5 JP 2016520636 A5 JP2016520636 A5 JP 2016520636A5 JP 2016517274 A JP2016517274 A JP 2016517274A JP 2016517274 A JP2016517274 A JP 2016517274A JP 2016520636 A5 JP2016520636 A5 JP 2016520636A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- phenyl
- acceptable salt
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1350684-5 | 2013-06-04 | ||
| SE1350684 | 2013-06-04 | ||
| PCT/EP2014/061501 WO2014195322A1 (en) | 2013-06-04 | 2014-06-03 | Triazole compounds and their use as gamma secretase modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016520636A JP2016520636A (ja) | 2016-07-14 |
| JP2016520636A5 true JP2016520636A5 (cg-RX-API-DMAC7.html) | 2017-06-01 |
| JP6396438B2 JP6396438B2 (ja) | 2018-09-26 |
Family
ID=50896282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016517274A Expired - Fee Related JP6396438B2 (ja) | 2013-06-04 | 2014-06-03 | トリアゾール化合物およびガンマセクレターゼモジュレーターとしてのその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9718805B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3004080B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6396438B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105263922B (cg-RX-API-DMAC7.html) |
| DK (1) | DK3004080T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2701810T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014195322A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11471449B2 (en) | 2015-02-25 | 2022-10-18 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease |
| EP4282479A3 (en) | 2015-02-25 | 2024-02-21 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to treat depression or anxiety |
| US10576125B2 (en) | 2016-10-31 | 2020-03-03 | Hough Ear Institute | Methods for enhancing synaptogenesis and neuritogenesis |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030312A1 (it) | 2003-02-21 | 2004-08-22 | Chiesi Farma Spa | Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer. |
| AU2004262970B2 (en) | 2003-08-07 | 2010-03-18 | Merck Sharp & Dohme Limited | Treatment for Alzheimer's disease and related conditions |
| AU2004295154A1 (en) | 2003-12-03 | 2005-06-16 | Merck & Co. Inc. | 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for Alzheimer's disease and related conditions |
| KR101128065B1 (ko) | 2004-05-26 | 2012-04-12 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물 |
| AU2007245435A1 (en) | 2006-04-26 | 2007-11-08 | Merck & Co., Inc. | Piperidines and related compounds for treatment of Alzheimer's disease |
| EP2019093A4 (en) | 2006-05-19 | 2011-02-23 | Eisai R&D Man Co Ltd | CINEMA ACID AMID DERIVATIVE FROM THE UREA TYPE |
| JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
| US8183276B2 (en) | 2007-02-08 | 2012-05-22 | Christian Fischer | Therapeutic agents |
| CA2676715A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
| CA2676920A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperidine derivatives |
| WO2008156580A1 (en) | 2007-06-13 | 2008-12-24 | Merck & Co., Inc. | Triazole derivatives for treating alzheimer's disease and related conditions |
| US20110009392A1 (en) | 2007-08-06 | 2011-01-13 | Schering Corporation | Gamma secretase modulators |
| EP2200990A1 (en) * | 2007-09-06 | 2010-06-30 | Schering Corporation | Gamma secretase modulators |
| CN101910142B (zh) | 2008-01-11 | 2013-07-10 | 弗·哈夫曼-拉罗切有限公司 | β-淀粉状蛋白的调节剂 |
| WO2009103652A1 (en) * | 2008-02-22 | 2009-08-27 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
| EP2367826A4 (en) | 2008-11-06 | 2012-07-04 | Astrazeneca Ab | MODULATORS OF THE PROTEIN -AMYLOID |
| CA2743196A1 (en) | 2008-11-10 | 2010-05-14 | F.Hoffmann-La Roche Ag | Heterocyclic gamma secretase modulators |
| TW201030002A (en) | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
| UY32622A (es) | 2009-05-12 | 2010-12-31 | Astrazeneca Ab | Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta) |
| AU2010272578B2 (en) | 2009-07-15 | 2015-03-05 | Cellzome Limited | Substituted triazole and imidazole derivatives as gamma secretase modulators |
| TWI468402B (zh) | 2009-07-31 | 2015-01-11 | 必治妥美雅史谷比公司 | 降低β－類澱粉生成之化合物 |
| AU2011206635B2 (en) | 2010-01-15 | 2015-01-22 | Cellzome Limited | Novel substituted triazole derivatives as gamma secretase modulators |
| US20110190269A1 (en) | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
| TW201206946A (en) | 2010-07-15 | 2012-02-16 | Bristol Myers Squibb Co | Compounds for the reduction of beta-amyloid production |
-
2014
- 2014-06-03 ES ES14728533T patent/ES2701810T3/es active Active
- 2014-06-03 EP EP14728533.2A patent/EP3004080B1/en not_active Not-in-force
- 2014-06-03 WO PCT/EP2014/061501 patent/WO2014195322A1/en not_active Ceased
- 2014-06-03 US US14/895,519 patent/US9718805B2/en not_active Expired - Fee Related
- 2014-06-03 DK DK14728533.2T patent/DK3004080T3/da active
- 2014-06-03 CN CN201480031629.0A patent/CN105263922B/zh not_active Expired - Fee Related
- 2014-06-03 JP JP2016517274A patent/JP6396438B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016520635A5 (cg-RX-API-DMAC7.html) | ||
| RU2017114355A (ru) | Производные нафтиридина в качестве антагонистов альфа v бета 6 интегрина для лечения, в частности, фиброзных заболеваний | |
| JP2017504611A5 (cg-RX-API-DMAC7.html) | ||
| JP2012508734A5 (cg-RX-API-DMAC7.html) | ||
| JP2016516043A5 (cg-RX-API-DMAC7.html) | ||
| JP2014513110A5 (cg-RX-API-DMAC7.html) | ||
| JP2017528504A5 (cg-RX-API-DMAC7.html) | ||
| JP2017528503A5 (cg-RX-API-DMAC7.html) | ||
| JP2019500352A5 (cg-RX-API-DMAC7.html) | ||
| JP2016538313A5 (cg-RX-API-DMAC7.html) | ||
| JP2017528506A5 (cg-RX-API-DMAC7.html) | ||
| HRP20120969T1 (hr) | Spoj azola | |
| UA110310C2 (uk) | Сполуки n-арилтриазолу як антагоністи рецепторів лізофосфатидної кислоти (lpar) | |
| JP2016522835A5 (cg-RX-API-DMAC7.html) | ||
| CL2015000578A1 (es) | Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer. | |
| SI3050882T1 (en) | Piperidin-4-yl azetidine derivatives, as inhibitors of JAK1 | |
| ME01462B (me) | Vinilindazolilna jedinjenja" | |
| JP2016513696A5 (cg-RX-API-DMAC7.html) | ||
| JP2018534286A5 (cg-RX-API-DMAC7.html) | ||
| JP2015522592A5 (cg-RX-API-DMAC7.html) | ||
| JP2015500223A5 (cg-RX-API-DMAC7.html) | ||
| AR068921A1 (es) | Derivados heterociclicos de tetrazol y 1,2-4 triazoles, composiciones farmaceuticas que los contienen y usos de los mismos para tratar desordenes neurologicos, gastrointestinales y del dolor,entre otros. | |
| JP2013506674A5 (cg-RX-API-DMAC7.html) | ||
| JP2017502063A5 (cg-RX-API-DMAC7.html) | ||
| MA46268A (fr) | Dérivés de 5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma |